Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin

• Yaëlle Bellahsen-Harrar,
• Marie Boisson,
• Baptiste Louveau,
• Barouyr Baroudjian,
• Thomas Aparicio,
• Valentine Ferré,
• Yann Parc,
• Aurélie Sadoux,
• Fanélie Jouenne,
• Maxime Battistella,
• Céleste Lebbé,
• Samia Mourah

Affiliations

Yaëlle Bellahsen-Harrar

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Department of Pathology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Correspondence to: Department of Pathology, Hôpital Henri Mondor, 1 rue Gustave Eiffel, F94010 Creteil Cedex, France.

Marie Boisson

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France

Baptiste Louveau

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France

Barouyr Baroudjian

Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, F-75010 Paris, France

Thomas Aparicio

Department of Gastroenterology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France

Valentine Ferré

Université Paris Cité, Inserm UMR 1137, IAME, F-75018 Paris, France; Department of Virology, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, F-75018 Paris, France

Yann Parc

Department of Gastrointestinal Surgery, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, F-75012 Paris, France

Aurélie Sadoux

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France

Fanélie Jouenne

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France

Maxime Battistella

Department of Pathology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France

Céleste Lebbé

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France; Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, F-75010 Paris, France

Samia Mourah

Department of Tumor Genomics and Pharmacology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France